Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment

Future Oncology, Ahead of Print.

Source: Future Oncology - December 13, 2023 Category: Cancer & Oncology Authors: Jennifer R Brown Barbara Eichhorst Peter Hillmen Wojciech Jurczak Maciej Ka źmierczak Nicole Lamanna Susan M O'Brien Constantine S Tam Lugui Qiu Keshu Zhou Martin Simkovic Jiri Mayer Amanda Gillespie-Twardy Alessandra Ferrajoli Peter S Ganly Robert Weink Source Type: research